Search

Brian M. Gulledge

Examiner (ID: 5324, Phone: (571)270-5756 , Office: P/1612 )

Most Active Art Unit
1612
Art Unit(s)
1699, 1612, 1619
Total Applications
1214
Issued Applications
625
Pending Applications
102
Abandoned Applications
497

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18815841 [patent_doc_number] => 20230390180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-07 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 18/323774 [patent_app_country] => US [patent_app_date] => 2023-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11186 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18323774 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/323774
None May 24, 2023 Abandoned
Array ( [id] => 20577137 [patent_doc_number] => 12569371 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-10 [patent_title] => Sterilization of medical dressings with enhanced antimicrobial properties [patent_app_type] => utility [patent_app_number] => 18/198469 [patent_app_country] => US [patent_app_date] => 2023-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 374 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18198469 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/198469
Sterilization of medical dressings with enhanced antimicrobial properties May 16, 2023 Issued
Array ( [id] => 19798808 [patent_doc_number] => 20250064733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => USE OF PEG-BASED INTERPOLYMER COMPLEXES FOR IMPROVED SOLUBILIZATION F BCS CLASS II DRUGS [patent_app_type] => utility [patent_app_number] => 18/842870 [patent_app_country] => US [patent_app_date] => 2023-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1618 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18842870 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/842870
USE OF PEG-BASED INTERPOLYMER COMPLEXES FOR IMPROVED SOLUBILIZATION F BCS CLASS II DRUGS May 16, 2023 Pending
Array ( [id] => 20206192 [patent_doc_number] => 20250275912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-04 [patent_title] => NOVEL COMPOSITION FOR IMPROVEMENT OF HAIR AND SCALP CONDITION [patent_app_type] => utility [patent_app_number] => 18/858779 [patent_app_country] => US [patent_app_date] => 2023-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18858779 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/858779
NOVEL COMPOSITION FOR IMPROVEMENT OF HAIR AND SCALP CONDITION Apr 20, 2023 Pending
Array ( [id] => 20031840 [patent_doc_number] => 20250170062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-29 [patent_title] => NON-LINEAR PEGYLATED LIPID CONTAINING A TERTIARY AMINE AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/839059 [patent_app_country] => US [patent_app_date] => 2023-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23627 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18839059 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/839059
NON-LINEAR PEGYLATED LIPID CONTAINING A TERTIARY AMINE AND APPLICATION THEREOF Apr 10, 2023 Pending
Array ( [id] => 18535900 [patent_doc_number] => 20230240986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => INHALABLE RAPAMYCIN FORMULATION FOR TREATING AGE-RELATED CONDITIONS [patent_app_type] => utility [patent_app_number] => 18/132743 [patent_app_country] => US [patent_app_date] => 2023-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25374 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18132743 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/132743
INHALABLE RAPAMYCIN FORMULATION FOR TREATING AGE-RELATED CONDITIONS Apr 9, 2023 Abandoned
Array ( [id] => 20082960 [patent_doc_number] => 20250212896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-03 [patent_title] => PROCESS FOR THE PREPARATION OF A HYDROLYZED EXTRACT OF NON-ANIMAL ORIGIN [patent_app_type] => utility [patent_app_number] => 18/850406 [patent_app_country] => US [patent_app_date] => 2023-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 593 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18850406 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/850406
PROCESS FOR THE PREPARATION OF A HYDROLYZED EXTRACT OF NON-ANIMAL ORIGIN Mar 29, 2023 Pending
Array ( [id] => 20039080 [patent_doc_number] => 20250177302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-05 [patent_title] => LIPOSOME COMPOSITION AND LIPOSOME-CONTAINING PHARMACEUTICAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/840179 [patent_app_country] => US [patent_app_date] => 2023-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2996 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18840179 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/840179
LIPOSOME COMPOSITION AND LIPOSOME-CONTAINING PHARMACEUTICAL COMPOSITION Mar 28, 2023 Pending
Array ( [id] => 21009731 [patent_doc_number] => 12746202 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-09-29 [patent_title] => Cationic lipid having disulfide bond, lipid membrane structure including same, nucleic acid introduction agent and pharmaceutical composition containing any one of same, method for introducing nucleic acid into cell or target cell, and method for producing cellular pharmaceutical [patent_app_type] => utility [patent_app_number] => 18/852405 [patent_app_country] => US [patent_app_date] => 2023-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22345 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18852405 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/852405
CATIONIC LIPID HAVING DISULFIDE BOND, LIPID MEMBRANE STRUCTURE INCLUDING SAME, NUCLEIC ACID INTRODUCTION AGENT AND PHARMACEUTICAL COMPOSITION CONTAINING ANY ONE OF SAME, METHOD FOR INTRODUCING NUCLEIC ACID INTO CELL OR TARGET CELL, AND METHOD FOR PRODUCING CELLULAR PHARMACEUTICAL Mar 23, 2023 Pending
Array ( [id] => 20371266 [patent_doc_number] => 12478681 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-25 [patent_title] => Non-activated, amorphous, pH neutral, two-part bedside-ready clay delivery system that treats pathogen infections in humans and animals [patent_app_type] => utility [patent_app_number] => 18/187224 [patent_app_country] => US [patent_app_date] => 2023-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 11747 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18187224 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/187224
Non-activated, amorphous, pH neutral, two-part bedside-ready clay delivery system that treats pathogen infections in humans and animals Mar 20, 2023 Issued
Array ( [id] => 20083612 [patent_doc_number] => 20250213548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-03 [patent_title] => PHARMACEUTICAL COMPOSITIONS FOR IMPROVING ORAL BIOAVAILABILITY [patent_app_type] => utility [patent_app_number] => 18/847553 [patent_app_country] => US [patent_app_date] => 2023-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18436 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -43 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18847553 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/847553
PHARMACEUTICAL COMPOSITIONS FOR IMPROVING ORAL BIOAVAILABILITY Mar 16, 2023 Pending
Array ( [id] => 20048264 [patent_doc_number] => 20250186486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-12 [patent_title] => POTENTIATION OF DURABLE ANTITUMOR IMMUNITY BY MULTIFACTORIAL IMMUNE MODULATION [patent_app_type] => utility [patent_app_number] => 18/843991 [patent_app_country] => US [patent_app_date] => 2023-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15887 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -165 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18843991 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/843991
POTENTIATION OF DURABLE ANTITUMOR IMMUNITY BY MULTIFACTORIAL IMMUNE MODULATION Mar 16, 2023 Pending
Array ( [id] => 20471976 [patent_doc_number] => 20260014194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-15 [patent_title] => COMBINATIONS COMPRISING METAP2 INHIBITORS FOR THE TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 18/846365 [patent_app_country] => US [patent_app_date] => 2023-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22208 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18846365 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/846365
COMBINATIONS COMPRISING METAP2 INHIBITORS FOR THE TREATMENT OF CANCER Mar 15, 2023 Pending
Array ( [id] => 19860561 [patent_doc_number] => 20250099347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-27 [patent_title] => ENCAPSULATED COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/842208 [patent_app_country] => US [patent_app_date] => 2023-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13163 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18842208 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/842208
Encapsulated compositions Mar 6, 2023 Issued
Array ( [id] => 18495969 [patent_doc_number] => 20230218487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => Depilatory Wax Additive and Process [patent_app_type] => utility [patent_app_number] => 18/177407 [patent_app_country] => US [patent_app_date] => 2023-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4177 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18177407 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/177407
Depilatory wax additive and process Mar 1, 2023 Issued
Array ( [id] => 18449328 [patent_doc_number] => 20230190604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => DERMATOLOGIC/PERSONAL CARE CONCENTRATES [patent_app_type] => utility [patent_app_number] => 18/111196 [patent_app_country] => US [patent_app_date] => 2023-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4302 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18111196 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/111196
DERMATOLOGIC/PERSONAL CARE CONCENTRATES Feb 16, 2023 Pending
Array ( [id] => 19875737 [patent_doc_number] => 20250107994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-03 [patent_title] => COMPOUND IN WHICH POLYGLYCEROL, FATTY ACID, AND DICARBOXYLIC ACID HAVE BEEN ESTERIFIED [patent_app_type] => utility [patent_app_number] => 18/844103 [patent_app_country] => US [patent_app_date] => 2023-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5991 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18844103 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/844103
Compound in which polyglycerol, fatty acid, and dicarboxylic acid have been esterified Feb 7, 2023 Issued
Array ( [id] => 19889008 [patent_doc_number] => 20250114320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-10 [patent_title] => MICROSPHERES FOR EXTENDED RELEASE OF FENOFIBRATE [patent_app_type] => utility [patent_app_number] => 18/836472 [patent_app_country] => US [patent_app_date] => 2023-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10775 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18836472 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/836472
MICROSPHERES FOR EXTENDED RELEASE OF FENOFIBRATE Feb 6, 2023 Pending
Array ( [id] => 20425248 [patent_doc_number] => 20250387335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-25 [patent_title] => Pharmaceutical Compositions, and Preparation and Methods of Use Thereof [patent_app_type] => utility [patent_app_number] => 18/835417 [patent_app_country] => US [patent_app_date] => 2023-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18685 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18835417 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/835417
Pharmaceutical Compositions, and Preparation and Methods of Use Thereof Feb 1, 2023 Pending
Array ( [id] => 20039079 [patent_doc_number] => 20250177301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-05 [patent_title] => TRIPLEX NANOPARTICLES [patent_app_type] => utility [patent_app_number] => 18/834513 [patent_app_country] => US [patent_app_date] => 2023-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41720 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18834513 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/834513
TRIPLEX NANOPARTICLES Jan 30, 2023 Pending
Menu